Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical Carcinoma
Author(s) -
Michael J. Crowley,
Theresa Scognamiglio,
Yifang Liu,
David A. Kleiman,
Toni Beninato,
Anna Aronova,
He Liu,
Yuliya Jhanwar,
Ana M. Molina,
Scott T. Tagawa,
Neil H. Bander,
Rasa Zarnegar,
Olivier Elemento,
Thomas J. Fahey
Publication year - 2016
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2015-4021
Subject(s) - medicine , adrenocortical carcinoma , positron emission tomography , immunohistochemistry , standardized uptake value , glutamate carboxypeptidase ii , pathology , prostate cancer , adrenocortical adenoma , pheochromocytoma , adenoma , carcinoma , cancer , nuclear medicine
Adrenocortical carcinoma (ACC) is a rare tumor type with a poor prognosis and few therapeutic options.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom